Background {#Sec1}
==========

Heart transplantation (HTx) is the preferred therapy for selected patients with end-stage heart failure \[[@CR1]\]. To improve physical capacity and health-related quality of life (HRQoL), cardiac rehabilitation is an integrated component in most HTx programs.

HRQoL is impaired prior to transplantation \[[@CR2]--[@CR4]\]. Longitudinal studies have reported that HRQoL improves significantly after HTx, with the greatest improvement occurring during the first half year \[[@CR2], [@CR5], [@CR6]\]. Most of the studies assessing long-term HRQoL after HTx have shown that HRQoL remains good up to five, \[[@CR2], [@CR7]\] ten \[[@CR8]\] and up to 20 \[[@CR9]\] years after transplant.

The physical domains in HRQoL are lower in HTx recipients than in the general population \[[@CR1], [@CR10]\], while the mental health domains has been found comparable to the general population \[[@CR7], [@CR8]\]. The physical functioning subscale in the Short-Form-36 (SF-36v2) is related to peak oxygen consumption (VO~2peak~), reflecting an association between self-reported physical function and objective measurements \[[@CR11], [@CR12]\]. The impact of exercise capacity on HRQoL has been studied at different time points after HTx \[[@CR11]--[@CR21]\]. Studies have found an association between improved exercise capacity and HRQoL \[[@CR11], [@CR19]\], but the effect of different exercise modes on HRQoL is unclear \[[@CR1]\], mainly due to lack of high-quality studies. Only one small study has examined the effect of high-intensity interval training (HIT) vs. moderate intensity continuous training (MICT) on HRQoL in maintenance HTx recipients, but found no difference between the two groups \[[@CR13]\]. The effect of HIT vs. MICT on HRQoL in newly heart transplanted recipients has not been studied, but these patients may have a greater potential for improvement in HRQoL \[[@CR1]\].

The aim of this study was to investigate the effect of HIT vs. MICT the first year after heart transplantation. We hypothesized that HIT would improve HRQoL more than MICT in de novo HTx recipients.

Methods {#Sec2}
=======

The study-design and other results has been described earlier \[[@CR22], [@CR23]\]. In short, it was a multi-center, randomized controlled trial comparing HIT vs. MICT in adult, consenting de novo HTx recipients. The trial was conducted at three transplant-centers in Scandinavia. The primary endpoint for the overall project was the change in VO~2peak~, while the prespecified endpoint for this substudy was the change in HRQoL. Eighty-one participants were included 7--16 weeks after HTx, and 78 were retested after nine months (Fig. [1](#Fig1){ref-type="fig"}). A permuted block randomization list was computer generated by a third party. Numbered sealed envelopes detailing the individual treatment allocation was prepared based on this list. Participants were assigned a randomization number at inclusion. After the CPET test at baseline, the envelope was opened and the patient was allocated to HIT or MICT. Fig. 1Patient recruitment and follow-up

Exercise intervention {#Sec3}
---------------------

The intervention is described elsewhere \[[@CR22], [@CR23]\]. Briefly, the participants were randomized 1:1, to either nine months of HIT or MICT at 11 ± 2 weeks after HTx. Participants in both groups exercised 2--3 times per week in the 9-month long intervention. The HIT consisted of 2--4 interval bouts at an intensity of 85--95% of maximal effort (corresponding to a rated perceived exertion (RPE) of 16--18). Between the HIT bouts, there was an active rest period (RPE 11--13). The goal for the HIT group was to be able to perform 4 interval bouts of 4 min length in the last intervention period. The MICT group followed the standard-of care exercise recommendations in recently HTx recipients, with an exercise intensity of 60--80% of maximal effort (corresponding to an RPE of 12--15) for a duration of 25 min. Both interventions included a 10 min warm up and a cool-down period of 5 min at the end of the exercise session. In addition, both groups performed strength training. All exercise sessions were performed in the participants' local communities, supervised by health personnel and all exercise sessions in both groups were logged and monitored with a heart rate monitor. Of 72 planned sessions, the HIT group completed median (interquartile range (IR)) 60 (28) sessions and the MICT group completed 56 (37) (p for difference 0.858).

Self-reported questionnaires {#Sec4}
----------------------------

HRQoL was assessed by the generic questionnaire SF-36v2, \[[@CR24]\] frequently used in HTx populations \[[@CR1], [@CR25]\]. The SF-36 is divided into eight subscales; Physical Functioning, Role Physical, Bodily Pain, General Health, Vitality, Social Functioning, Role Emotional and Mental Health. The eight subscales aggregate into two summary scores; a Physical Component and a Mental Component; higher score indicating better HRQoL. In this study, all scores were transformed to norm-based values with a standardized mean of 50 and a standard deviation (SD) of 10. A change of 2--4 points on any item is considered to be of clinical significance \[[@CR24]\].

Symptoms of anxiety and depression were measured with the Hospital Anxiety and Depression Scale (HADS) \[[@CR26]\]. The participants' socio-demographic background was assessed by a simple questionnaire at baseline and at follow-up. Additionally, at follow-up, all the participants recorded: *"To what extent do you feel participation in this study had a positive impact on your general health and well-being"* on a numeric visual analogue scale (VAS), ranging from "not at all" to "to a very great extent".

All the questionnaires were self-administered and filled out during the study visits at both time points (Fig. [2](#Fig2){ref-type="fig"}). The Physical Functioning subscale from SF-36v2 was selected to represent self-reported physical function. Fig. 2Design of the study

Exercise testing {#Sec5}
----------------

All participants underwent a cardiopulmonary exercise test (CPET) with measurements of VO~2peak~ at baseline and at follow-up. Most of the Norwegian participants (*n* = 70) in were tested on a treadmill with breath-by-breath gas analysis (Jaeger® Masterscreen® CPX, Carefusion), and four of the particpants were tested on a bicycle (Schiller Cardiovit® CS-200 Excellence). The participants from Sweden and Denmark (n = 7) were tested on a bicycle (Jaeger®,Oxy Con Pro® and Jaeger® Vyntus® CPX). The CPET tests was performed with an individualized protocol with a gradual increase in workload until exhaustion \[[@CR22], [@CR27]\]. Isokinetic muscle strength and muscular exercise capacity in the lower limbs were measured with a dynamometer (Cybex 6000) \[[@CR22], [@CR23], [@CR28]\].

Ethics {#Sec6}
------

All participants provided written informed consent prior to inclusion. The study was approved by the regional ethic committees in Norway, Sweden and Denmark. The study is conducted according to the Helsinki Declaration. <https://clinicaltrials.gov/> identifier NCT01796379.

Statistics {#Sec7}
----------

Continuous data are expressed as mean ± SD, or median (IR). Categorical data are presented as number and percentages. An intention-to-treat analysis were conducted. Differences between the two groups were investigated with independent Student t -tests and with Mann-Whitney U tests where appropriate. The change (delta value) for each participant between baseline and 1-year follow-up was calculated by subtracting the results at 1-year follow-up with the results at baseline \[Change = 1-year follow-up -- baseline\]. The change was assessed by independent t-tests to calculate the mean difference in change between the two groups in normally distributed variables, and by Mann-Whitney U tests for variables with skewed distribution. Within-group differences were analyzed with Paired-Sample t-tests and Wilcoxon Signed Rank tests. We assessed associations between HRQoL scores and parameters reflecting exercise capacity using Pearson's and Spearman's correlations. Missing data in the SF-36v2 were handled by the "half-scale" rule, which means that a scale score was calculated if at least half of the items of that specific scale were answered \[[@CR24]\]. For the two HADS scales, scores were calculated for those with complete data only. All data were analyzed using IBM SPSS 25.0 (IBM Corporation, United States). *P* values \< 0.05 (two-sided) were considered statistically significant.

Results {#Sec8}
=======

Demographic data are provided in Table [1](#Tab1){ref-type="table"}. There were no differences between the intervention arms regarding baseline socio-demographic or clinical characteristics. Table 1Baseline characteristics in the HIT group and the MICT group^a^VariablesHIT (*n* = 37)MICT (*n* = 41)Sex n (%) men28 (76)29 (71)Age (years)50 ± 1248 ± 14Body Mass Index kg/m^2^24.8 ± 3.425.6 ± 3.9In a relationship (married/cohabitant)22 (61)30 (73)Employed8 (22)9 (22)Primary diagnosis n (%) CM/CAD/Other21 (57) / 14 (38) / 2 (5)31 (75) / 6 (15) / 4 (10) Donor age (years)37 ± 1439 ± 14 Ischaemic time (min)181 ± 77184 ± 82 Median (IR) years of HF duration pre HTx4.0 (9.1)4.5 (8.1) Median (IR) days on waitlist85 (192)71 (167) Smoking (n (%) No/Ex-smoker)18 (49) / 19 (51)21 (51) / 20 (49) Biomarkers Hemoglobin (g/dL)11.8 ± 1.811.7 ± 1.6 Creatinine (μmol/L)116.1 ± 33.9118.5 ± 28.0 eGFR (mL/min/1.73m^2^)65.1 ± 20.962.7 ± 23.3 HbA1c (%)5.7 ± 0.95.6 ± 0.7Medication at inclusion n (%) Ciclosporine24 (65)31 (76) Tacrolimus11 (30)10 (24) Everolimus12 (32)13 (32) Prednisolone37 (100)41 (100) Mycophenolate34 (92)36 (88) Statin36 (97)41 (100) Beta blocker9 (24)12 (30) Calcium blocker8 (22)12 (30) ACE inhibitor02 (5) ARB4 (11)3 (8) Diuretics31 (84)32 (78)Variables are presented as mean ± standard deviation, median (interquartile range (IR)) or number (percentages). *ACE* angiotensin converting enzyme, *ARB* angiotensin II reseptor blocker, *CAD* coronary artery disease, *CM* cardiomyopathy, *eGFR* estimated glomerular filtration rate (Chronic Kidney Disease Epidemiology Collaboration calculation), *HbA1c* hemoglobin A1c, *HF* heart failure, *HIT* High-intensity interval training, *HTx* heart transplantation, *MICT* moderate intensity contionuous training^a^No difference between groups

All HRQoL variables were similar in the two groups at baseline. Symptoms of depression and anxiety were low in both groups at baseline (Table [2](#Tab2){ref-type="table"}). Table 2Baseline and follow-up results in the HIT group and the MICT group^d^VariablesBaselineFollow-up\
HIT\
(*n* = 37)t-test, *P* valueBaselineFollow-up\
MICT\
(*n* = 41)t-test, *P* valueHealth-related quality of life SF-36v2 components summaries and subscales Physical Component Summary (PCS)42.2 ± 7.648.4 ± 9.3\<  0.00143.2 ± 7.749.0 ± 8.4\< 0.001 Mental Component Summary (MCS)52.5 ± 12.953.4 ± 11.90.67355.1 ± 8.252.5 ± 9.60.086 Physical Functioning45.0 ± 7.050.8 ± 6.0\< 0.00146.4 ± 6.451.6 ± 6.6\< 0.001 Role Physical37.6 ± 10.448.1 ± 9.3\< 0.00140.8 ± 10.047.0 ± 10.0\< 0.001 Bodily Pain47.8 ± 9.350.5 ± 10.50.16348.1 ± 9.249.1 ± 12.20.583 General Health48.2 ± 9.450.8 ± 11.00.06749.8 ± 7.351.2 ± 9.40.292 Vitality50.6 ± 10.852.6 ± 12.70.19651.2 ± 9.453.6 ± 9.00.031 Social Functioning46.7 ± 9.950.2 ± 9.10.04748.7 ± 8.750.7 ± 9.00.278 Role Emotional46.8 ± 13.152.0 ± 9.10.02750.7 ± 7.748.7 ± 10.50.246 Mental Health53.1 ± 11.053.7 ± 9.70.68455.4 ± 7.854.0 ± 9.70.232 HADS Anxiety median (IR)3.0 (3.5)2.0 (4.5)0.310^a^3.0 (3.5)3.0 (4)0.400^a^ HADS Depression median (IR)2.0 (3.5)2.0 (4.8)0.331^a^1.0 (2.5)1.0 (3.8)0.866^a^ VAS scale (0--100) median (IR)^b^82.0 (20.5)75.5 (37.3)0.235^c^Cardiopulmonary exercise test VO~2peak~ (mL/kg/min)19.5 ± 4.324.4 ± 6.5\< 0.00121.3 ± 5.324.4 ± 6.7\< 0.001 % of predicted VO~2peak~53.3 ± 11.666.6 ± 15.4\< 0.00158.4 ± 12.566.9 ± 14.8\< 0.001 RPE (Borg scale score)18.7 ± 0.518.8 ± 0.60.29018.5 ± 1.118.8 ± 0.70.098 RER1.17 ± 0.111.19 ± 0.10.3141.22 ± 0.131.22 ± 0.10.751Muscular capacity Maximal muscle strength extensors (Newton meter)184 ± 74237 ± 81\< 0.001186 ± 73222 ± 80\< 0.001 Muscular exercise capacity extensors (Joule)2154 ± 9523170 ± 1267\< 0.0012319 ± 12012870 ± 1240\< 0.001Health-related quality of life, exercise capacity and muscular strength at baseline (\~ 11 weeks after HTx and at 9 months intervention (first yearly annual follow-up). Variables are presented as mean ± standard deviation or median (Interquartile range (IR)).*HADS* Hospital Anxiety and Depression Scale, *HIT* High-intensity interval training, *MICT* moderate intensity contionuous training, *RER* Respiratory exchange ratio, *RPE* Rated perceived exertion, *VAS* visual analogue scale^a^Wilcoxon Signed Rank Test^b^Measured at follow-up only^c^Mann-Whitney U test (difference between groups at follow-up)^d^No difference between groups at baseline

During the intervention, the scores for the SF-36v2 subscales Physical Functioning and Role Physical improved significantly in both exercise arms (Table [2](#Tab2){ref-type="table"}). The improvement in these scales exceeded two points, which is regarded a clinically important difference \[[@CR24]\]. Accordingly, the Physical Component Summary scores improved significantly (Table [2](#Tab2){ref-type="table"}). The Mental Component Summary scores were above 50 at baseline, while HADS scores were low. Neither the Mental Component Summary scores nor the HADS scores did change significantly during the intervention period (Table [2](#Tab2){ref-type="table"}).

The participants' general health and well-being was good, as shown on the VAS scale. At follow-up, the HIT group scored 82 points and the MICT group scored 76 (p for difference = 0.235) (Table [2](#Tab2){ref-type="table"}). Table 3Comparison of change between the HIT group and the MICT group from baseline to follow-upVariablesChange within the HIT group\
Mean ± SD\
(*n* = 37)Change within the MICT group\
Mean ± SD\
(*n* = 41)Difference in mean change between groups\
mean \[95% CI\]*P* value Difference in change between groupsHealth-related quality of life SF-36v2 components summaries and subscales Physical Component Summary (PCS)6.3 ± 8.2^\*\*^5.7 ± 5.7^\*\*^0.6 \[− 3.1, 4.2\]0.762 Mental Component Summary (MCS)0.9 ± 12.5− 2.6 ± 9.33.4 \[− 1.5, 8.5\]0.170 Physical Functioning5.8 ± 5.6^\*\*^5.2 ± 5.6^\*\*^0.6 \[− 2.0, 3.2\]0.653 Role Physical10.5 ± 11.2^\*\*^6.2 ± 10.0^\*\*^4.3 \[− 0.6, 9.1\]0.082 Bodily Pain2.7 ± 11.51.0 ± 11.41.7 \[− 3.5, 6.9\]0.509 General Health2.6 ± 8.31.4 ± 8.61.1 \[− 2.7, 4.9\]0.555 Vitality2.0 ± 9.22.6 ± 7.3^\*^− 0.6 \[− 4.3, 3.2\]0.760 Social Functioning3.6 ± 10.5^\*^2.0 ± 11.61.5 \[− 3.5, 6.5\]0.541 Role Emotional5.2 ± 13.4^\*^− 2.0 ± 117.2 \[1.6, 12.8\]0.012 Mental Health0.6 ± 9.0− 1.4 ± 7.32.0 \[− 1.7, 5.7\]0.284 HADS Anxiety−1.0^a^−0.8^a^0.920^c^ HADS Depression−1.0^b^−0.2^a^0.427^c^Cardiopulmonary exercise test VO~2peak~ (mL/kg/min)4.8 ± 4.1^\*\*^3.1 ± 3.5^\*\*^1.8 \[0.1, 3.5\]0.044 Improvement in mL/kg/min (%)25.2 ± 21.1^\*\*^15.1 ± 17.8^\*\*^10.1 \[1.3, 19.0\]0.025 % of predicted VO~2peak~13.2 ± 10.7^\*\*^8.5 ± 9.1^\*\*^4.7 \[0.2, 9.2\]0.040 RPE (Borg scale score)0.1 ± 0.80.3 ± 1.20.2 \[−0.3, 0.7\]0.424 RER0.02 ± 0.1−0.01 ± 0.10.02 \[− 0.03, 0.1\]0.338Muscular capacity Maximal muscle strength extensors (Newton meter)54 ± 49^\*\*^36 ± 34^\*\*^178 \[− 3, 39\]0.094 Muscular exercise capacity extensors (Joule)1016 ± 812^\*\*^551 ± 780^\*\*^464 \[63, 863\]0.024Health-related quality of life, exercise capacity and muscular strength at baseline (\~ 11 weeks after HTx and at 9 months intervention (first yearly annual follow-up). Variables are presented as mean ± standard deviation. *CI* Confidence Interval, *HADS* Hospital Anxiety and Depression Scale, *HIT* High-intensity interval training, *MICT* moderate intensity contionuous training, *SD* standard deviation, *RER* Respiratory exchange ratio, *RPE* Rated perceived exertion, *VAS* visual analogue scaleWithin group: ^\*\*^*p* \< 0.001, ^\*^*p* \< 0.05^a^Based on negative ranks^b^Based on positive ranks^c^Mann-Whitney U test

As reported earlier, there was a significant between-group difference in increased VO~2peak~ over the intervention period, in favor of HIT \[[@CR23]\] (Table [3](#Tab3){ref-type="table"}). However, there were no differences between the two exercise arms in HRQoL, the main endpoint of this substudy, except on the Role Emotional subscale, which covers the spectrum of mental health-related role constraints related to work or other daily activities \[[@CR24]\] (Table [3](#Tab3){ref-type="table"}). Maximal RPE (Borgs scale score) were equal between the two groups and did not change during the intervention period \[[@CR23]\] (Table [3](#Tab3){ref-type="table"}).

There were no differences between groups regarding rejections or serious/adverse events during the intervention period \[[@CR23]\].

There was a positive correlation between VO~2peak~ and the self-reported physical function in both groups, both at baseline (Fig. [3](#Fig3){ref-type="fig"}) and at follow-up (Fig. [4](#Fig4){ref-type="fig"}). In the HIT group, we found a modest correlation between the change from baseline to 1-year follow-up in self-reported physical function and the change in VO~2peak~ (Pearson's *r* = 0.35, *p* = 0.03). There was no correlation between the corresponding changes in the MICT group (Pearson's *r* = − 0.13, *p* = 0.41). Fig. 3Correlation between self-reported physical function and VO~2peak~ in the high-intensity training (HIT) group and the moderate intensity continuous training (MICT) group mean 11 weeks after heart transplantation (HTx)Fig. 4Correlation between self-reported physical function and VO~2peak~ in the high-intensity training (HIT) group and the moderate intensity continuous training (MICT) group 1 year after heart transplantation (HTx)

The self-reported physical function also correlated with the extensors' maximal muscle strength and muscle endurance at both time points in both groups (See Additional File [1](#MOESM1){ref-type="media"}, Figs. [1](#Fig1){ref-type="fig"}, [2](#Fig2){ref-type="fig"}, [3](#Fig3){ref-type="fig"} and [4](#Fig4){ref-type="fig"}).

The SF-36 Role Physical scale correlated modestly with VO~2peak~ in both groups at 1-year follow-up. Correlations between other CPET values (heart rate variables, O~2~ pulse, maximal ventilation, respiratory exchange ratio, RPE) and SF-36 subscales were weak in both groups at both time points. However, there was a moderate correlation between metabolic equivalents and self-reported physical function in both groups at both time points (data not shown).

Missing data in the questionnaires {#Sec9}
----------------------------------

There was little missing data. At baseline there were 1.3% missing for the following SF-36 subscales; Role Physical, Vitality and Mental Health and 2.6% missing for the Role Emotional subscale and each of the two SF-36 sum scores. At follow-up there were 1.3% missing for all of the SF-36 subscales except of General Health and Social Functioning, while there were 2.6% missing for each of the two SF-36 sum scores and for each of the HADS scores.

Discussion {#Sec10}
==========

The main findings in the present study were: 1) In patients who had recently undergone HTx, the Physical Component Scores improved significantly during the nine-months long intervention period, and 2) There were no differences in HRQoL between patients allocated to HIT or MICT, except on the Role Emotional subscale where the HIT group had a significantly higher score.

Maintenance HTx recipients tend to score lower than the general population on the physical function domains of HRQoL \[[@CR7], [@CR8]\]. Interventions to improve physical function in HTx recipients are of special interest since improved physical function is associated with better HRQoL \[[@CR11], [@CR17]\] and is a strong predictor for survival \[[@CR12]\].

In exercise trials comparing HIT with a control group in maintenance HTx recipients, improvements in general health is higher in the intervention groups \[[@CR14], [@CR15]\]. These results suggest that exercise has a positive effect on HRQoL in the long term after HTx. In line with our findings, Hsu et al. \[[@CR16]\] observed improved HRQoL in the physical function domains of SF-36 after cardiac rehabilitation early after HTx. It should be noticed that neither our study, nor the study by Hsu et al., \[[@CR16]\] had a control group without an exercise program. The relatively high HRQoL observed at the end of our trial, and in the study by Hsu et al. \[[@CR16]\] may reflect an overall improved health status during the first year after HTx, rather than an effect of exercise alone. For example, Ortega et al. \[[@CR29]\] found improvements in SF-36 physical domains over the first year after HTx without an intervention.

To our knowledge, only one prior study has investigated the effect of HIT vs. MICT on HRQoL in HTx recipients \[[@CR13]\]. In this crossover trial (*n* = 16), \[[@CR13]\] there were no differences between the groups regarding HRQoL, symptoms of anxiety or depression, which is in line with our results. However, the same study found a significant decrease in symptoms of anxiety in the HIT group, and a significant decrease in symptoms of depression in both groups. This contrasts our study, where symptoms of depression and anxiety were low and stable throughout the intervention period in both groups.

The improvement in the Role Emotional subscale in our patients randomized to HIT may reflect an improved sense of achievement associated with exhaustive exercise, but may also be an incidental finding.

We found correlations between VO~2peak~ and self-reported physical function at both time points, as previously reported in maintenance HTx recipients \[[@CR19]\]. The correlation between the change in self-reported physical function and the change in VO~2peak~ from baseline to 1-year follow-up was observed in the HIT group only. This may be due to the higher mean change in VO~2peak~ in the HIT group compared to the MICT group. VO~2peak~ and self-reported physical function are strong predictors for long-term survival after HTx \[[@CR12]\]. Obtaining self-reported physical function is less resource-demanding than performing CPET with measurements of VO~2peak~. However, the correlation between the two is modest, and self-reported physical function cannot fully substitute VO~2~ measurements in the short and in the longer term after HTx.

Limitations {#Sec11}
-----------

The high baseline HRQoL scores may reflect an above average healthy population and may also have affected the impact of the intervention on HRQoL. For obvious reasons, the sickest patients could not be enrolled in the trial. Thus, our results may not be valid for the entire HTx population. HRQoL was a secondary, but prespecified endpoint in the HITTS (High-intensity Interval Training in De Novo Heart Transplant Recipients in Scandinavia) study \[[@CR22], [@CR23]\]. With only 78 participants we may face a type II error due to insufficient statistical power.

A disease-specific HRQoL questionnaire could have been more sensitive to detect differences between groups. So far, no disease-specific questionnaires in Norwegian are available for the HTx population. In a prior HTx study, we experienced a ceiling effect using the heart failure-specific Kansas City Cardiomyopathy Questionnaire \[[@CR30]\] and decided not to use this questionnaire in this study.

The HITTS trial \[[@CR22], [@CR23]\] was not designed to assess the participants´ daily activities and the roles they were hoping to assume*.* This limits our ability to explain the between-group difference in the Role Emotional scale.

Clinical implications and future directions {#Sec12}
-------------------------------------------

Interventions for good and stable HRQoL, both short- and long-term after HTx, are needed. Exercise yields better physical function and makes it easier to engage in various activities of everyday life. However, despite improved VO~2peak~ with the HIT intervention, HRQoL was similar in both intervention arms. The development of an organ transplant-specific HRQoL questionnaire is warranted for future research in this field, \[[@CR25]\] as it probably will be more accurate to detect changes in health status associated with organ transplant issues.

Conclusion {#Sec13}
==========

This randomized controlled trial demonstrated significant improvements in the physical function components in HRQoL over a nine-month long exercise intervention in de novo HTx recipients. However, despite a larger improvement in exercise capacity in the HIT group, there were no between-group differences regarding the change in HRQoL.
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 {#Sec14}

**Additional file 1: Figure 1.** Correlation between self-reported physical function and maximal muscle strength in the high-intensity training group and the moderate intensity continuous training group 11 weeks after heart transplantation (HTx). **Figure 2.** Correlation between self-reported physical function and maximal muscle strength in the high-intensity training group and the moderate intensity continuous training group 1 year after heart transplantation (HTx). **Figure 3.** Correlation between self-reported physical function and muscle endurance in the high-intensity training group and the moderate intensity continuous training group 11 weeks after heart transplantation (HTx). **Figure 4.** Correlation between self-reported physical function and muscle endurance in the high-intensity training group and the moderate intensity continuous training group 1 year after heart transplantation (HTx).
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